Cancer Genetics Inc (NASDAQ:CGIX)

0.9291
Delayed Data
As of 9:37am ET
 -0.00087 / -0.09%
Today’s Change
0.82
Today|||52-Week Range
4.35
-49.78%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Cancer Genetics Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +545.76% increase from the last price of 0.93.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Hold stock in Cancer Genetics Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.09
Sales
$10.0M
Reporting Date
Aug 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 46.88%
 
 
 
 
 
 
Growthannually 67.33%
 
 
 
 
 
 

Sales

Growthquarterly 30.72%
 
 
 
 
 
 
Growthannually 33.83%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.